Please login to the form below
UK Biobank reveals new data from world's largest genetic project
The data will accelerate the development of potentially lifesaving treatments and cures
New study finds dose of Mavenclad treatment could predict MS relapse risk
The disease affects approximately 130,000 people in the UK and currently has no cure
Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
Vasomotor symptoms affect up to 80% of menopausal women in the US
GSK global survey reveals misunderstandings about shingles in adults
About 55% of respondents believe that shingles can be caught from someone else
Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
The partnership is aimed at discovering oral inhibitors of a PPI target selected by Lilly
First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
Experts in areas including cancer, AMR and neurological diseases participated
Merck shares positive phase 3 results for investigational pneumococcal vaccine in adults
V116 is designed to address the strains responsible for adult pneumococcal disease
New report reveals antibiotic underdosing could be leading cause of AMR in UK
AMR has been declared by WHO as one of the top ten threats to global public health
Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
The collaboration will see Boehringer use an IBM-developed AI model to boost its drug discovery efforts
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
New blood test to reduce heart attacks and death rates in A&E heart patientsThe test could improve diagnosis for one in five patients with a heart muscle injury
-
GSK shares positive phase 3 results for Blenrep combination in multiple myelomaApproximately 176,000 new cases of multiple myeloma are diagnosed globally each year
-
Stem cell therapy trial shows promising results for treating progressive MSThe early-stage trial shows the potential to develop an advanced cell therapy treatment
-
Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients
About one-third of adults living with diabetes die from a heart or circulatory disease
-
Sanofi/Regeneron’s Dupixent shows promise in chronic obstructive pulmonary diseaseAbout 300,000 people in the US have uncontrolled COPD and type 2 inflammation
-
UK government and NIHR accelerate plans to improve clinical research deliveryThe government has created a focused plan for action to transform UK clinical research
-
Novo Nordisk announces $2.3bn investment to expand production site in FranceThe investment will increase the manufacturing capacity for Novo's GLP-1 products
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life SciencesCaulfield served as chief scientist at Genomics England, working on the 100,000 Genomes Project
-
AZ appoints Susan Galbraith as executive vice president, oncology R&DGalbraith’s appointment into the role follows the passing of José Baselga earlier this year
-
AZ appoints Alexion’s Aradhana Sarin as chief financial officerSarin will become AZ's new chief financial officer upon closing of the company’s acquisition of Alexion Pharmaceuticals
-
Doina Ionescu elected to ABPI’s board of directorsIonescu is managing director and general manager for Merck Healthcare UK and Ireland
-
CureVac taps Klaus Edvardsen for chief development officer roleEdvardsen joins the German biopharma company from Merck KGaA
Latest research appointments
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
